Whitehawk Therapeutics (WHWK) Operating Leases (2019 - 2024)
Whitehawk Therapeutics (WHWK) reported Operating Leases of $565000.0 for Q4 2024, down 32.17% year-over-year from $833000.0 in Q1 2024, and down 40.27% quarter-over-quarter from $946000.0 in Q3 2024.
Whitehawk Therapeutics (WHWK) Operating Leases (2019 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 6 years of Operating Leases data on file, last reported at $565000.0 in Q4 2024.
- Operating Leases for Q4 2024 came in at $565000.0, down 32.17% year-over-year; the trailing twelve-month figure through Dec 2024 was $565000.0 (down 32.17% YoY), and the FY2024 annual result was $565000.0, down 32.17% from the prior year.
- Operating Leases declined to $565000.0 in Q4 2024 per WHWK's latest filing, from $946000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $1.8 million in Q2 2022 and troughed at $9955.0 in Q2 2020.
- A 5-year average of $825320.4 and a median of $785500.0 in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2020 and 2023: Operating Leases sank 96.54% in 2020, then soared 174.53% in 2023.
- A 5-year view of Operating Leases shows it stood at $9955.0 in 2020, then soared by 4661.43% to $474000.0 in 2021, then soared by 167.3% to $1.3 million in 2022, then tumbled by 34.25% to $833000.0 in 2023, then plunged by 32.17% to $565000.0 in 2024.
- Business Quant data shows WHWK's Operating Leases at $565000.0 in Q4 2024, $946000.0 in Q3 2024, and $682000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 565,000.00 |
| Sep 30, 2024 | 946,000.00 |
| Jun 30, 2024 | 682,000.00 |
| Mar 31, 2024 | 738,000.00 |
| Dec 31, 2023 | 833,000.00 |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.06 Mn |
| Mar 31, 2023 | 1.16 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 1.77 Mn |
| Mar 31, 2022 | 424,000.00 |
| Dec 31, 2021 | 474,000.00 |
| Sep 30, 2021 | 523,000.00 |
| Jun 30, 2020 | 9,955.00 |
| Mar 31, 2020 | 39,171.00 |
| Dec 31, 2019 | 67,438.00 |
| Sep 30, 2019 | 236,223.00 |
| Jun 30, 2019 | 288,055.00 |
| Mar 31, 2019 | 337,737.00 |